Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00459355 · ClinicalTrials.gov registry record · Phase 1

Home Safety Clinical Trial for Alzheimer's Disease

A Phase 1 study of Dementia and Alzheimers Disease, sponsored by US Department of Veterans Affairs.

Completed
Registry status
Phase 1
Development phase
254
Enrollment target
1
Study location

NCT00459355 is a Phase 1 study of Dementia and Alzheimers Disease that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 254 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00459355, a Phase 1 study of Dementia and Alzheimers Disease, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
Phase 1
Development phase
254 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to test the effectiveness of a new multimodal educational intervention to improve home safety for persons with dementia of the Alzheimer's type and their home caregivers.

Interventions

  • BEHAVIORAL Home Safety Toolkit

Study Locations (1)

Massachusetts

  • Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA - Bedford

Trial Details

FieldValue
Enrollment Target 254 participants
Start Date 2007-07
Est. Completion 2011-12
Phase Phase 1

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00459355

The ClinicalTrials.gov registry entry for NCT00459355 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which Home Safety Toolkit is the first listed.

NCT00459355 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00459355 about?

NCT00459355 is a clinical study titled "Home Safety Clinical Trial for Alzheimer's Disease". The purpose of this study was to test the effectiveness of a new multimodal educational intervention to improve home safety for persons with dementia of the Alzheimer's type and their home caregivers.

What is the current status of trial NCT00459355?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 254 participants. The study started on 2007-07. Estimated completion is 2011-12.

What conditions does trial NCT00459355 study?

This clinical trial studies the following conditions: Dementia, Alzheimers Disease.

What interventions are being tested in trial NCT00459355?

The interventions under investigation include: Home Safety Toolkit (BEHAVIORAL).

Who is sponsoring clinical trial NCT00459355?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00459355 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.